Method of assaying adenocarcinoma antigens

Details Method of assaying adenocarcinoma antigens Method of assaying adenocarcinoma antigens

G - Physics

01

N

167/44

G01N 33/574 (2006.01) G01N 33/535 (2006.01) G01N 33/577 (2006.01)

Patent

CA 1286606

ABSTRACT OF THE DISCLOSURE Adenocarcinoma antigens in serum samples are assayed immobilizing, or a solid phase, a first antibody which is a mixture of anti-human lung adenocarcinoma monoclonal anti- body ALC-186 and anti-human stomach adenocarcinoma mono- clonal antibody AMC-382, allowing a human serum sample to react with the first antibody to bind adenocarcinoma antigens, allowing a second antibody which is a mixture of anti-human lung adenocarcinoma monoclonal antibody ALC-186 and anti-human stomach adenocarcinoma monoclonal antibody AMC-382 each in an enzyme-labeled form to react with the adenocarcinoma antigens and thereafter determining the quantity of the thus-bound second antibody by measuring the activity of the labeling enzyme.

533473

Affiliated with

Also associated with

Rating

Method of assaying adenocarcinoma antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of assaying adenocarcinoma antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of assaying adenocarcinoma antigens will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1269554